Nifty 50
- Infosys₹999.757.75 (0.78%)
- Adani Enterprises₹2,578.40-164.60 (-6.00%)
- Tech Mahindra₹1,497.306.20 (0.42%)
- JSW Steel₹1,178.70-51.30 (-4.17%)
- Titan Company₹4,388.1011.10 (0.25%)
- ITC₹255.25-10.45 (-3.93%)
- Axis Bank₹1,244.902.40 (0.19%)
- Max Healthcare₹872.35-35.65 (-3.93%)
- HCL Technologies₹1,186.701.70 (0.14%)
- InterGlobe Aviation₹4,811-179.00 (-3.59%)
- Trent₹2,891.801.50 (0.05%)
- Adani Ports₹1,690.20-59.90 (-3.42%)
- Apollo Hospitals₹7,651.50-265.50 (-3.35%)
- Bharat Electronics₹367.20-11.10 (-2.93%)
- Tata Motors PV₹274.90-8.10 (-2.86%)
- Shriram Finance₹922.20-25.80 (-2.72%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Alivus Life Sciences Share Price Today
As of 08-10-2026 15:23, Alivus Life Sciences Ltd. share price today is ₹0, with a change of ₹-1370.20 (-100.00%) from the previous close of ₹1370.2. The stock opened at ₹1370.2 and traded between ₹1320.3 and ₹1371.9, with a total traded volume of 73866 shares. The company has a market capitalization of ₹16991.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1493.8 and ₹819, respectively.
Alivus Life Sciences Ltd. valuation metrics include a P/E ratio of 28.2, and book value of ₹4.90. Profitability indicators show ROE of 16.94% along with a dividend yield of 0.4%. Alivus Life Sciences Ltd. has reported revenue of ₹2590.4 Cr and net profit of ₹603.02 Cr.
Alivus Life Sciences Ltd. technical indicators include Day RSI at 53.57, Day MFI at 47.94, Day ADX at 18.82. Additional indicators include Commodity Channel Index (CCI) at -10 and Williams %R at -48.1. Momentum indicators show Day MACD at 6.31, Day MACD Signal Line at 10.39, DayATR at 48.12. Rate of Change indicators for Alivus Life Sciences Ltd. include ROC125 at 37.63 and ROC21 at -2.45.
Exponential moving averages include EMA5 at ₹1375.6, EMA10 at ₹1375.1, EMA12 at ₹1375.4, EMA20 at ₹1374.1, EMA26 at ₹1369.1, EMA50 at ₹1331.1, EMA100 at ₹1248.6, EMA200 at ₹1151.3. Simple moving averages include SMA5 at ₹1373.6, SMA10 at ₹1370.6, SMA20 at ₹1379.1, SMA30 at ₹1380.6, SMA50 at ₹1346.8, SMA100 at ₹1218.9, SMA150 at ₹1147.5, SMA200 at ₹1087.3.
Support levels for Alivus Life Sciences are placed at First Support ₹1360.57, Second Support ₹1337.13, Third Support ₹1320.07. Resistance levels are seen at First Resistance ₹1401.07, Second Resistance ₹1418.13, Third Resistance ₹1441.57. Alivus Life Sciences Ltd. shareholding pattern shows promoter holding at 74.87%, FII holding at 5.54%, DII holding at 0%, public holding at 12.42%.
Alivus Life Sciences Performance
Price Movement
₹1320.30
₹1371.90
1 Year Performance
₹819.00
₹1493.80
Markets Today
Historical Performance
Alivus Life Sciences Fundamentals
Alivus Life Sciences Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 640.41 | 689.12 | 672.89 | 587.98 | 601.85 |
| Operating Expense | 428.70 | 474.59 | 441.62 | 408.81 | 429.54 |
| Operating Profit | 211.71 | 214.53 | 231.27 | 179.17 | 172.31 |
| Depreciation | 20.58 | 20.20 | 19.66 | 18.44 | 17.06 |
| Interest | 1.31 | 1.31 | 1.49 | 1.32 | 1.25 |
| Tax | 52.15 | 53.14 | 48.13 | 44.11 | 41.45 |
| Net Profit | 160.08 | 162.66 | 150.26 | 130.03 | 121.54 |
Alivus Life Sciences Technicals
Alivus Life Sciences Ltd. EMA & SMA
₹1343.30
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Alivus Life Sciences Support and Resistance
Resistance
Support
Technical Indicators
Alivus Life Sciences Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 74.9 | 74.9 | 74.9 | 74.9 | 74.9 |
| FII | 6.6 | 6.4 | 6.8 | 5.1 | 5.3 | 5.5 |
| DII | 5.2 | 5.6 | 5.5 | 7.1 | 7.3 | 7.2 |
| Public | 13.2 | 13 | 12.8 | 12.9 | 12.6 | 12.4 |
Alivus Life Sciences Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.35 L | 1.91 L | 70.89% |
| Week | 93.18 K | 1.5 L | 62.25% |
| 1 Month | 82.49 K | 1.42 L | 57.95% |
| 6 Month | 77.9 K | 1.49 L | 52.37% |
Alivus Life Sciences SWOT Analysis
Companies with no Debt
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Alivus Life Sciences Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 01 Sep, 2026 | 5 | FINAL | 01 Sep, 2026 | Equity Share |
| 01 Sep, 2025 | 5 | FINAL | 01 Sep, 2025 | Equity Share |
| 17 Oct, 2023 | 22.5 | INTERIM | 17 Oct, 2023 | Equity Share |
| 24 Mar, 2023 | 21 | INTERIM | 24 Mar, 2023 | Equity Share |
| 15 Sep, 2022 | 10.5 | FINAL | Equity Share | |
| 22 Nov, 2021 | 10.5 | INTERIM | 23 Nov, 2021 | Equity Share |
Alivus Life Sciences Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,097.40 | ₹1,991.60 | ₹1,124.60 | ₹1,321.50 | ₹1,477 | ₹3,584.90 |
| % Change | -3.36% | -2.43% | -3.91% | -4.90% | -3.38% | -3.71% |
| Revenue TTM (₹ Cr) | - | ₹1,479.07 | ₹675.61 | ₹691.72 | ₹1,543.34 | ₹949.80 |
| Net Profit TTM (₹ Cr) | - | ₹199.03 | ₹182.64 | ₹126.37 | ₹-48.62 | ₹266 |
| PE TTM | - | 62.70 | 71.60 | 50.60 | -362.20 | 32.40 |
| 1 Year Return | 16.35 | 92.09 | 95.35 | 93.38 | -17.96 | -22.12 |
| ROCE | 14.97 | 31.54 | 24.22 | 15.60 | 0.59 | - |
Similar Stocks
AKUMS
Akums Drugs & Pharmaceuticals Ltd.
₹ 788.05
-4.19%
INNOVACAP
Innova Captab Ltd.
₹ 1130.10
-3.10%
BLUEJET
Blue Jet Healthcare Ltd
₹ 519.65
-4.01%
CONCORDBIO
Concord Biotech Ltd.
₹ 1330.00
-2.18%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 879.75
-7.72%
SUPRIYA
Supriya Lifescience Ltd.
₹ 859.25
-3.37%
COHANCE
Cohance Lifesciences Ltd.
₹ 441.20
-3.13%
ERIS
Eris Lifesciences Ltd.
₹ 1160.50
+1.28%
SYNGENE
Syngene International Ltd.
₹ 346.80
-3.75%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 803.80
-3.60%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 188.96
-3.98%
STAR
Strides Pharma Science Ltd.
₹ 1075.60
-2.27%
FDC
FDC Ltd.
₹ 325.00
-1.08%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 935.00
-4.06%
NATCOPHARM
Natco Pharma Ltd.
₹ 801.80
-1.02%
MARKSANS
Marksans Pharma Ltd.
₹ 310.00
-4.75%
ORCHPHARMA
Orchid Pharma Ltd.
₹ 984.15
-3.89%
IOLCP
IOL Chemicals and Pharmaceuticals Ltd.
₹ 208.94
-5.12%
VIYASH
Viyash Scientific Ltd.
₹ 237.99
-1.15%
ASTRAZEN
AstraZeneca Pharma India Ltd.
₹ 5777.50
-2.37%
BLISSGVS
Bliss GVS Pharma Ltd.
₹ 667.35
-2.08%
SANOFI
Sanofi India Ltd.
₹ 2984.40
-1.30%
PFIZER
Pfizer Ltd.
₹ 3741.60
-1.93%
MOREPENLAB
Morepen Laboratories Ltd.
₹ 139.82
-4.86%
FAQ's on ALIVUS
What is the current share price of Alivus Life Sciences Ltd.?
What is the Market Capitalization of Alivus Life Sciences Ltd.?
What are the PE and PB ratios for Alivus Life Sciences Ltd.?
What is the 52-Week High and Low for Alivus Life Sciences Ltd.?
What is the current dividend yield for Alivus Life Sciences Ltd.?
Who are the major shareholders of Alivus Life Sciences Ltd.?
Who are the peers of Alivus Life Sciences Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Alivus Life Sciences Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy